Nova Eye Medical Ltd (EYE.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Sales | 29,267 | 23,325 | 17,025 | 13,631 | 13,394 |
| Cost of Goods | 9,201 | 3,132 | 2,631 | 2,289 | 2,243 |
| Gross Profit | 20,066 | 20,193 | 14,394 | 11,342 | 11,151 |
| Operating Expenses | 31,312 | 29,161 | 26,388 | 21,041 | 16,318 |
| Operating Income | -11,246 | -8,968 | -11,994 | -9,699 | -5,167 |
| Interest Expense | N/A | N/A | N/A | N/A | 5 |
| Other Income | 2,187 | 178 | -5,008 | 1,453 | -78 |
| Pre-tax Income | -9,059 | -8,790 | -17,002 | -8,246 | -5,250 |
| Income Tax | 0 | 0 | -1,709 | -750 | -894 |
| Net Income Continuous | -9,059 | -8,790 | -15,293 | -7,496 | -4,356 |
| Net Income | $-9,059 | $-8,790 | $-15,293 | $-7,496 | $-4,356 |
| EPS Basic Total Ops | -0.04 | -0.04 | -0.10 | -0.05 | -0.03 |
| EPS Basic Continuous Ops | -0.04 | -0.04 | -0.10 | -0.05 | -0.03 |
| EPS Diluted Total Ops | -0.04 | -0.04 | -0.10 | -0.05 | -0.03 |
| EPS Diluted Continuous Ops | -0.04 | -0.04 | -0.10 | -0.05 | -0.03 |
| EBITDA(a) | $-8,985 | $-5,979 | $-9,697 | $-7,888 | $-3,730 |